RxDoctor Payments Data

Gregory Berland, MD

Family Medicine · Tampa, FLNPI 1265427405

Payments from drug & device makers

$6,700in general payments, 2019–2025

Across 395 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$939
  • Pfizer$510
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$450
  • Amarin Pharma, Inc.$391
  • Astellas Pharma US Inc$349
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$6,65899%
  • Education$421%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,700 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$276,796
Medicare patients
544
Services billed
2,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban267$250,419
OzempicSemaglutide92$117,252
JardianceEmpagliflozin92$80,375
MounjaroTirzepatide66$77,022
XareltoRivaroxaban68$60,572
EntrestoSacubitril/Valsartan44$49,229
MyrbetriqMirabegron72$38,092
Tresiba Flextouch U-200Insulin Degludec15$30,310
LatudaLurasidone Hcl12$26,256
FarxigaDapagliflozin Propanediol25$25,695
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$23,231
VascepaIcosapent Ethyl19$19,833
JanuviaSitagliptin Phosphate21$13,064
TrulicityDulaglutide11$12,402
Levothyroxine Sodium832$8,760

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$510$250,419267 claims
Novo NordiskOzempic$1,187$117,25292 claims
Lilly USA, LLCMounjaro, Trulicity$257$89,42477 claims
Boehringer IngelheimJardiance$136$80,37592 claims
Johnson & JohnsonXarelto$177$60,57268 claims
NovartisEntresto$87$49,22944 claims
Astellas Pharma US IncMyrbetriq$349$38,09272 claims
GSKTrelegy Ellipta, Incruse Ellipta$270$27,27932 claims
AstraZenecaFarxiga$205$25,69525 claims
MerckJanuvia$37$13,06421 claims
AbbVieSynthroid$939$4,16967 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →